Cordyceps Sinensis Market -Regional Insights
Geographically, the global CordycepsSinensis Extract Market is segmented into North America, Latin America,Europe, Asia Pacific, Middle East, and Africa. North America is expected tolead the market during the forecast period, followed by Europe.
High prevalence of chronicdiseases in the U.S. is expected to be a major factor supporting the marketgrowth. According to Centre for Disease Control and Prevention, seven of thetop ten causes of deaths in the U.S., in 2014 were chronic diseases, heartdiseases, and cancer, which together accounted for over 46% of the deaths inthe country. Furthermore, increasing number of patients with mental disordersis expected to significantly expand adoption of cordyceps sinensis extracts asit has immense benefits in lowering symptoms related to mental disorder.According to Anxiety and Depression Association of America in 2017, anxietydisorders are the most common mental illness in the U.S., affecting around 40million adults aged 18 years and above, or 18.1% of the population, annually.However, only 36.9% of those suffering from anxiety receive treatment.
Asia Pacific is expected to showsignificant growth in the global cordyceps sinensis extract market over theforecast period. This is due the region being a major producer of cordycepssinensis extracts, especially in China. According to data presented by theMinistry of Agriculture and Rural Affairs of the Peoples Republic of China in2011, China has 200,000 kg of Cordyceps and 120,000 kg was harvested. Qinghaiand Tibet regions exports around 20,000 kg of cordyceps sinensis to the U.S.,Japan, Korea, Europe, South East Asia, Hong Kong, Macao and Taiwan etc. with anannual export of over 20,000 kg. Furthermore, rising prevalence of chronic diseases and increasingadoption of traditional medicines for the treatment of such diseases in theregion is expected to propel growth of the cordyceps sinensis extract market.As per World Health Organizations’ factsheet in 2018, 1 in 3
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1983
Cordyceps Sinensis also called asophiocordyceps sinensis is combination of parasitic fungus species and deadcaterpillars that offer several potential health applications. It has been inuse in traditional Chinese and Tibetan medicines as remedy for around 21ailments such as low immunity, high blood pressure etc. Cordyceps spores growsinside the caterpillar’s body and infects it, thus slowly degrading the livinglarva and mummifies it in the soil. A cordyceps stem eventually emerges fromhead part of the caterpillar.
Major active ingredients incordyceps sinensis extract include cordycepin, adenosine, exopolysaccharidefraction (EPSF), cordyglucans, and monosaccharide saponin. Scientific studiesand clinical trials found that cordyceps sinensis extract can aid treatment ofdiabetes, high cholesterol, and hypertension. Furthermore, it boosts immunityand acts as stress reliever in stress related disorders.
Cordyceps Sinensis is available as healthsupplement in tablet, powder, and capsule form in major developed markets.Regulatory bodies such as USFDA has have approved use of cordyceps sinensisextract as dietary supplement.
Cordyceps Sinensis Market -Market Dynamics
Cordyceps sinensis offersmedicinal properties such as cholesterol reduction, stimulation of the immunesystem, faster recovery from bronchitis, and other respiratory diseases, andincreases efficiency of the circulatory system. Furthermore, it has anti-cancerproperties and can be used in treatment of liver-associated diseases. Itprovides enhanced recovery from chemotherapy, improves libido, a general bodyadaptogen (enhanced body energy and strength)
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/cordyceps-sinensis-extract-market-1983
High prevalence of chronicdiseases such as cardiovascular disease, cancer, diabetes, and respiratorydiseases would lead to increasing adoption of preventive healthcare productsmade from cordyceps sinensis extracts, which in turn would aid in growth of thecordyceps sinensis extract market. According to World Health Organizationsstatistics, in 2018, non-communicable diseases are responsible for over 41 milliondeaths, annually, which is equivalent to 71% of all deaths, worldwide.Furthermore, according to the same source cardiovascular diseases causes over17.9 million deaths annually, followed by cancer (9.0 million), respiratorydiseases (3.9million), and diabetes (1.6 million), respectively.
High prevalence of autoimmune andstress related disorders across the world, especially in developed regions suchas North America and Europe. According to American Autoimmune Related DiseaseAssociation, more than 50 million people in the U.S. were affected byautoimmune disease in 2017. This would be another major factor driving growthof the cordyceps sinensis extract market. Increased preference for naturalremedy for correcting chronic disease is new trend in world including U.S.
However, high cost of cordycepssinensis extracts is expected to be a major factor deterring the market growth.Insufficient clinical evidence for many diseases such as cancer and diabetesmay limit market growth for cordyceps sinensis extract. Furthermore, it isdifficult to scale up the artificial cultivation of cordyceps sinensis species.High cost of cordyceps sinensis in the international market often leads tomalpractice of adulteration and substitution in the extracts.
Cordyceps Sinensis Market -Competitive Landscape
Key players operating in theglobal cordyceps sinensis market include Naturalin, Active Organics, Quyuansunnycare Inc., Kangzhou, HERBSINO, SOST, Health Choice Limited, Zhongke Group,and Nutra Green.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1983
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
